Invest now

Artemis Medicare Services share price

Balanced risk
  • 36%Low risk
  • 36%Moderate risk
  • 36%Balanced risk
  • 36%High risk
  • 36%Extreme risk
  • 314.60(-1.29%)
    August 14, 2026 15:29:08 PM IST
    • NSE
    • BSE
  • Vol : 177.08 K (NSE + BSE)
    Last 20 day avg : 505.79 K
Artemis Medicare Services is trading -1.29% lower at Rs 314.60 as compared to its last closing price. Artemis Medicare Services has been trading in the price range of 320.00 & 312.00. Artemis Medicare Services has given 17.27% in this year & 1.97% in the last 5 days. Artemis Medicare Services has TTM P/E ratio 36.86 as compared to the sector P/E of 22.24.There are 4 analysts who have initiated coverage on Artemis Medicare Services. There are 2 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 31.31 Crores in its last quarter.Listed peers of Artemis Medicare Services include Apollo Hospitals Enterprise (3.84%), Max Healthcare Institute (0.09%), Fortis Healthcare (3.43%).The Mutual Fund holding in Artemis Medicare Services was at 1.30% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in Artemis Medicare Services was at 12.28% in 30 Jun 2026. The FII holding has increased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Loading...
Key Metrics

Updated on 14 Aug 2026, 09:51 PM IST

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    2.18
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.28
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.14
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    5.38
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    44.29
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.34
    Indicates Fair Valuation
Price range
Day Range
Lowest
312.00
Highest
320.00
52 week range
Lowest
202.85
Highest
325.80
Artemis Medicare Services Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Apollo Hospitals Enterprise
8,925.003.841,28,327.8064.9313.390.2353.80
Max Healthcare Institute
1,010.000.0998,300.6171.479.870.1827.71
Fortis Healthcare
935.003.4370,588.5967.897.270.1029.68
Aster DM Healthcare
824.00-0.0142,693.17102.559.260.4944.74
Narayana Hrudayalaya
1,833.200.1437,504.3948.079.080.22121.59
Mutual Fund Ownership
View all
LIC MF Focused Fund Growth
2/5
  • Amount Invested (Cr.) 6.23
  • % of AUM 4.43
LIC MF Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 3.05
  • % of AUM 3.61
LIC MF Value Fund Growth
1/5
  • Amount Invested (Cr.) 3.49
  • % of AUM 2.12
HSBC Focused Fund Regular Growth
3/5
  • Amount Invested (Cr.) 34.94
  • % of AUM 2.10
LIC MF Childrens Fund
NA
  • Amount Invested (Cr.) 0.31
  • % of AUM 1.99
Artemis Medicare Services Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-08-03Quarterly Results
2026-06-04Others
2026-05-08Audited Results & Final Dividend
2026-02-02Quarterly Results & Others
2025-11-11Quarterly Results
About the company Artemis Medicare Services
  • IndustryHealthcare Facilities
  • ISININE025R01021
  • BSE Code542919
  • NSE CodeARTEMISMED
Artemis Medicare Services Limited is an India-based company. The Company manages and operates a multi-specialty hospital. It specializes in a range of advanced medical and surgical interventions, a mix of inpatient and outpatient services. It offers treatment facilities for various medical conditions under various specialties, which include allergy and immunology, blood (hematology), bones, muscles and joints (orthopedics), brain, spine and nervous system, cancer (oncology), circulatory (vascular), dermatology, digestive (gastroenterology), endocrine, diabetes and cardiology, infectious diseases, sleep apnea, kidneys stone treatment and failure (renal), lung (pulmonary), mouth, teeth and face (oral and maxillofacial), obstetrics and gynecology, psychiatry, arthritis and joint disease, surgery, and urology. It also offers treatment for irregular periods, vertigo, finger joint treatment, and piles. The Company's subsidiary includes Artemis Cardiac Care Private Limited.
  • Management Info
  • Sanjiv KothariChief Financial Officer
  • Poonam MakkarCompliance Officer, Company Secretary
  • Devlina ChakravartyManaging Director, Executive Director
Artemis Medicare Services Share Price FAQs

Artemis Medicare Services is trading at 314.60 as on Fri Aug 14 2026 09:59:08. This is -1.29% lower as compared to its previous closing price of 318.70.

The market capitalization of Artemis Medicare Services is 4976.95 Cr as on Fri Aug 14 2026 09:59:08.

The average broker rating on Artemis Medicare Services is Strong Buy. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 2 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Artemis Medicare Services is 325.80 whereas the 52 wk low is 202.85

Artemis Medicare Services can be analyzed on the following key metrics -

  • TTM P/E: 36.86
  • Sector P/E: 22.24
  • Dividend Yield: 0.14%
  • D/E ratio: -

Artemis Medicare Services reported a net profit of 103.62 Cr in 2026.

The Mutual Fund Shareholding was 1.30% at the end of 30 Jun 2026.